Posted on August 30, 2007 by Albin Paul
Scientists from the Lucile Packard Children’s Hospital and the Stanford University School of Medicine have identified a pattern of gene expression shared by a small group of patients who beat the odds and remained [...]
Filed under: DNA, DNA diagnostics, Genomics, Pharmacogenomics, biodefense, bioinformatics blog, cancer, clinical genomics, gene expression, gene therapy, genetic medicine, genetics, microaray blog, transgenomics | 4 Comments »
Posted on March 9, 2007 by Albin Paul
Junk DNA is not junk after all
Recently, scientists at the University of Oxford have discovered that ‘junk’ genetic material can switch off cancer tumours, preventing them from growing.
By using RNA to switch off a gene involved in controlling cell division, Oxford University scientists may have found a role for RNA in developing new cancer therapies. [...]
Filed under: DNA, DNA microarray, Next Generation of DNA and RNA Microarrays, Pharmacogenomics, RNA, RNA microarray, bacteria, biodefense, bioinformatics, bioinformatics blog, clinical diagnostics, clinical microarray, digital, drug development, drug discoverry, epigenetics, gene expression, genetics, genotyping, microaray blog, microarray, microarray analysis, microarray for clinical diagnostics, outsource, personalized medicine | No Comments »
Posted on March 1, 2007 by Albin Paul
Researchers from The Weizmann Institute of Science report the discovery of two new properties of the genetic code. Their work, which appears online in Genome Research, shows that the genetic code—used by organisms as diverse as reef coral, termites, and humans—is nearly optimal for encoding signals of any length in parallel to sequences that code [...]
Filed under: DNA, DNA microarray, bacteria, biodefense, bioinformatics, bioinformatics blog, bioinformatics software, drug development, drug discoverry, drug resistance, epigenetics, gene expression, genetics, genotyping, microaray blog, microarray | 3 Comments »
Posted on February 16, 2007 by Albin Paul
A novel invention developed by a scientist from New York Institute of Technology (NYIT) could revolutionize biological and clinical research and may lead to treatments for cancer, AIDS, Alzheimer’s, diabetes, and genetic and infectious diseases.
The invention allows the immobilisation of intact. double-stranded, multi-stranded or alternative DNA or RNA and has the potential to revolutionise [...]
Filed under: Affymetrix, Clinical microarrays, DNA microarray, Next Generation of DNA and RNA Microarrays, Pharmacogenomics, RNA microarray, biodefense, bioinformatics, cancer, cancer microarray, clinical diagnostics, clinical microarray, custom microarray, drug development, drug discoverry, gene expression, genetics, genotyping, microarray, microarray analysis, microarray for clinical diagnostics, personalized medicine | 2 Comments »